Research progress of pulmonary hypertension in risk stratification of acute pulmonary embolism
WU Nan1 XING Xiqian2 YANG Jiao1▲
1.Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Kunming Medical University, Yunnan Province, Kunming 650032, China; 2.Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Yunnan University, Yunnan Province, Kunming 650021, China
Abstract：Acute pulmonary embolism (APE) has a high mortality rate in China. Early correct risk stratification of APE patients can improve the prognosis of patients. The traditional risk stratification is based on the patient’s hemodynamics as a reference. Currently, pulmonary arterial pressure in APE patients is a hot topic of clinical attention, and the incidence of clinical adverse events in APE patients with pulmonary arterial hypertension is generally increased. At the same time, some biomarkers, such as brain natriuretic peptide, D-dimer, cardiac troponin I are related to pulmonary artery pressure. These indicators also have reference value for risk stratification and prognosis of APE patients. This article reviews the pathophysiology and pulmonary artery pressure of APE, as well as the combination of the three biomarkers mentioned above, in the risk stratification and prognosis of APE patients, providing new ideas for APE risk stratification.
[1] Hong J，Lee JH，Lee JY，et al. Prominent seasonal variation in pulmonary embolism than deep vein thrombosis incidence：a Korean venous thrombosis epidemiology study [J]. Korean J Intern Med，2020，35（3）：682-691.
[2] Hobohm L，Sebastian T，Valerio L，et al. Trends in mortality related to pulmonary embolism in the DACH countries [J]. Med Klin Intensivmed Notfmed，2022，117（6）：428-438.
[3] Tomkiewicz EM，Kline JA. Concise review of the clinical approach to the exclusion and diagnosis of pulmonary embolism in 2020 [J]. J Emerg Nurs，2020，46（4）：527-538.
[4] Zaboli A，Turcato G，Solazzo P，et al. Effectiveness of manchester triage system in risk prioritisation of patients with pulmonary embolism who present dyspnoea，chest pain or collapse [J]. Int Emerg Nurs，2020，50：1008842.
[5] 姜秀国.急性肺栓塞患者早期临床表现及诊断探究[J].医学食疗与健康，2020，18（20）：171-172.
[6] 覃少佳，邓碧玉，张鸿魁，等.中危肺栓塞诊断和治疗的研究进展[J].中外医学研究，2019，17（3）：186-188.
[7] Hepburn-Brown M，Darvall J，Hammerschlag G. Acute pulmonary embolism：a concise review of diagnosis and management [J]. Intern Med J，2019，49（1）：15-27.
[8] Thakur R，Singhal M，Aggrawal AN，et al. Comparison of high-pitch prospective electrocardiogram-gated pulmonary CT angiography with standard CT pulmonary angiography on dual-source CT for detection of subsegmental pulmonary embolism in patients suspected of acute pulmonary embolism [J]. Pol J Radiol，2022，87：e296-e303.
[9] Rivera-Lebron B，McDaniel M，Ahrar K，et al. Diagnosis，treatment and follow up of acute pulmonary embolism：consensus practice from the PERT consortium [J]. Clin Appl Thromb Hemost，2019，25：1076029619853037.
[10] Nie Y，Sun L，Long W，et al. Clinical importance of the distribution of pulmonary artery embolism in acute pulmonary embolism [J]. J Int Med Res，2021，49（4）：3000605 211004769.
[11] 蔡春霞，张乃锦.彩色多普勒超声对下肢深静脉血栓的诊断价值[J].影像研究与医学应用，2020，4（23）：118- 119.
[12] Schultz J，Andersen A，Gade IL，et al. Riociguat，sildenafil and inhaled nitric oxide reduces pulmonary vascular resistance and improves right ventricular function in a porcine model of acute pulmonary embolism [J]. Eur Heart J Acute Cardiovasc Care，2020，9（4）：293-301.
[13] Fernandes CJ，Luppino Assad AP，Alves-Jr JL，et al. Pulmonary embolism and gas exchange [J]. Respiration，2019， 98（3）：253-262.
[14] Lyhne MD，Schultz JG，Kramer A，et al. Right ventricular adaptation in the critical phase after acute intermediate-risk pulmonary embolism [J]. Eur Heart J Acute Cardiovasc Care，2021，10（3）：243-249.
[15] Singh S，Lewis MI. Evaluating the right ventricle in acute and chronic pulmonary embolism：current and future considerations [J]. Semin Respir Crit Care Med，2021，42（2）：199-211.
[16] 王辰.肺血栓栓塞症诊治与预防指南[J].中华医学杂志，2018，98（14）：1060-1087.
[17] 王海峰.超声心动图测量肺动脉高压对急性肺栓塞患者的危险分层及预后的应用价值[J].临床肺科杂志，2017， 22（3）：476-478.
[18] 饶显群，王玮，袁超，等.急性肺栓塞并发肺动脉高压的临床特征分析[J].南京医科大学学报（自然科学版），2019，39（2）：253-255.
[19] Maron BA，Kovacs G，Vaidya A，et al. Cardiopulmonary hem- odynamics in pulmonary hypertension and heart failure：JACC review topic of the week [J]. J Am Coll Cardiol，2020， 76（22）：2671-2681.
[20] 梁芳，王在义.肺动脉高压对急性肺栓塞中危险分层及预后评估的作用[J].临床肺科杂志，2015，20（2）：272- 275.
[21] Moumneh T，Wells PS，Miranda S. Risk stratification of pulmonary embolism [J]. Crit Care Clin，2020，36（3）：437- 448.
[22] Matusov Y，Singh I，Yu YR，et al. Chronic thromboembolic pulmonary hypertension：the bedside [J]. Curr Cardiol Rep，2021，23（10）：147.
[23] Yu Y，Yang L，Zhang Y，et al. Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world [J]. Clin Respir J，2018，12（11）：2551-2558.
[24] Klok FA，Barco S，Konstantinides SV，et al. Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension：results from the European CTEPH Registry [J]. Eur Respir J，2018，52：1801687.
[25] Konstantinides SV，Meyer G. The 2019 ESC Guidelines on the diagnosis and management of acute pulmonary embolism [J]. Eur Heart J，2019，40（42）：3453-3455.
[26] Janisset L，Castan M，Poenou G，et al. Cardiac biomarkers in patients with acute pulmonary embolism [J]. Medicina（Kaunas），2022，58（4）：541.
[27] Chen YL，Wright C，Pietropaoli AP，et al. Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team [J]. J Thromb Thro- mbolysis，2020，49（1）：34-41.
[28] Jia D，Liu F，Zhang Q，et al. Rapid on-site evaluation of routine biochemical parameters to predict right ventricular dysfunction in and the prognosis of patients with acute pulmonary embolism upon admission to the emergency room [J]. J Clin Lab Anal，2018，32（4）：e22362.
[29] Geissenberger F，Schwarz F，Probst M，et al. D-dimer predicts disease severity but not long-term prognosis in acute pulmonary embolism [J]. Clin Appl Thromb Hemost，2019， 25：1076029619863495.
[30] Polo Friz H，Pezzetti V，Orenti A，et al. Comorbidity burden conditions the prognostic performance of D-dimer in elderly patients with acute pulmonary embolism [J]. Am J Emerg Med，2019，37（5）：799-804.
[31] 杨丹，胡海.DAGMAR评分法在胸痛患者急性肺栓塞院内急诊预检分诊中的价值[J].成都医学院学报，2022， 17（3）：346-349.
[32] 刘萍，曾强，宋珊，等.D-二聚体和纤维蛋白原及CT肺动脉阻塞指数与肺栓塞危险程度的关系研究[J].实用心脑肺血管病杂志，2020，28（7）：108-112.
[33] 庞颖颖，刘海涛.生物标志物与急性肺栓塞危险分层及预后的关联性研究[J].中华全科医学，2022，20（2）：199- 201，281.
[34] Leidi A，Bex S，Righini M，et al. Risk stratification in patients with acute pulmonary embolism：current evidence and perspectives [J]. J Clin Med，2022，11（9）：2533.
[35] Ebner M，Guddat N，Keller K，et al. High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism [J]. ERJ Open Res，2020，6（4）：625.
[36] 夏洁.急性肺栓塞合并肺动脉高压危险因素分析[D].重庆：重庆医科大学，2018.
[37] 谭志敏，李科，许东明，等.急性肺栓塞患者合并与不合并肺动脉高压时肌钙蛋白I及氨基末端脑钠肽前体水平的差异[J].临床和实验医学杂志，2017，16（12）：1184-1187.
京公网安备 11010502046598号